WPF urges HHS National Vaccine Advisory Committee to extend privacy protections of vaccination information

In public testimony September 15, 2021, WPF’s Executive Director urged the Department of Health and Human Services National Vaccine Advisory Committee Committee to establish broadened protections for covid-19 vaccination data, including extending the existing CDC Guidance (from May 2021) prohibiting commercial marketing use of vaccination registration information or other vaccination data. The intersection between HIPAA privacy regulations

WPF supports CDC guidance prohibiting use of vaccine recipients’ data for commercial marketing purposes, urges that protections are extended to proof of vaccination systems

WPF’s Executive Director spoke today before the US Center For Disease Control’s ACIP Committee regarding privacy protections for vaccine recipients’ data. WPF supported the CDC’s prohibition on the use of vaccine recipient data for commercial marketing purposes. The CDC’s Vaccination Program Provider Requirements, published in May 18, 2021, specifically prohibits the commercial marketing use of

WPF urges the Federal Reserve Board of Governors to ensure quality assurance and control mechanisms for biometric authentication in debit card payment systems 

In comments filed with the Federal Reserve Board of Governors, WPF supported proposed language for Comment 235.7 (A)-1, Scope of Restriction, with the understanding that more needs to be done to determine and set quality assurance measures for debit card payment system authentication methods in general, and for biometric methods in particular. WPF requests that

C20 – G20 Global Dialogue on Health, WPF statement

On August 4, 2021, WPF participated as a member of the Civil20 – G20 Global Dialogue on Health. The dialogue was moderated by C20 Global Health co-chair Rachel Ong, with concluding comments by co-chair Kurt Frieder. Davide La Cecilia, Diplomatic adviser to the Italian Minister for Health and former Ambassador of Italy to Ukraine, participated